(Science Daily) Alzheimer's disease (AD) is an incurable, progressive neurodegenerative disease affecting over five million people worldwide, and is the leading cause of dementia in the elderly. Currently, intravenous human immunoglobulin (IVIG) treatment is being explored in multiple off-label uses other than immunotherapy, including AD. Several clinical studies assessing the tolerability and efficacy of IVIG in Alzheimer's disease subjects are in progress with inconsistent outcomes…
Dr. [Giulio Maria] Pasinetti and his team of investigators recently found that prolonged administration of human immunoglobulin in models of Alzheimer's disease … is effective at attenuating Alzheimer's disease-type cognitive dysfunction while promoting synaptic plasticity.
Community: There are a number of practical things we can do to prevent, delay, or lessen the severity of Alzheimer's Disease.
[Click the title, above, to post a comment.]